Anticonvulsant Activity of 3-Oxo-5-substituted Benzylidene-6-methyl-(4//)-2-pyridazinylacetamides and 2-Pyridazinylacetylhydr azides

52Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

A series of 3-oxo-5-substituted-benzylidene-6-methyl-(4//)-2-pyridazinylacetamides and 2-pyridazinylacetylhydra-zides were synthesized and evaluated for anticonvulsant activity against electrically and chemically induced seizures. In the maximal electroshock-induced seizures test, most of the derivatives showed an anticonvulsant effect better than that of sodium valproate, a commonly used anticonvulsant drug. At 100 mg/kg orally, compounds 5a and 5b respectively protected 50 and 60% of the mice against pentylentetrazole-induced seizures. In addition, these two derivatives showed significant anticonvulsant properties at doses that did not produce ataxia or sedation. The title compounds were also tested for their ability to antagonize convulsions induced by bicuculline and strychnine. Their effect on tremors induced by oxotremorine in mice was also evaluated. © 1990, The Pharmaceutical Society of Japan. All rights reserved.

Cite

CITATION STYLE

APA

Rubat, C., Coudert, P., Refouvelet, B., Tronche, P., Bastide, P., & Bastide, J. (1990). Anticonvulsant Activity of 3-Oxo-5-substituted Benzylidene-6-methyl-(4//)-2-pyridazinylacetamides and 2-Pyridazinylacetylhydr azides. Chemical and Pharmaceutical Bulletin, 38(11), 3009–3013. https://doi.org/10.1248/cpb.38.3009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free